Published in Ter Arkh on January 01, 1976
[Effects of probiotic bifiform on efficacy of Helicobacter pylori infection treatment]. Ter Arkh (2006) 0.76
[Etiologic and pathologic approaches to pharmacotherapy of peptic ulcer]. Ter Arkh (1991) 0.75
[Differential diagnosis of thyroid cancer]. Klin Med (Mosk) (1972) 0.75
[Treatment of cholelithiasis]. Sov Med (1988) 0.75
[Determination of the functional state of the thyroid gland by use of the DSU-61 unit in a locality with endemic goiter]. Probl Endokrinol Gormonoter (1967) 0.75
[Comparative clinico-morphological characteristics of endemic goiter in Amur district]. Vestn Khir Im I I Grek (1973) 0.75
[Diagnosis of Campylobacter pylori in chronic gastritis, gastric ulcer and duodenal ulcer (review of the literature)]. Lab Delo (1990) 0.75
[Comparative evaluation of the efficacy of monotherapy with cimetidine and combined treatment of the recurrent duodenal ulcer]. Ter Arkh (1983) 0.75
[Constipation: from the symptom to the diagnosis and adequate treatment]. Ter Arkh (1996) 0.75
[Certain characteristics of the condition of the gastroduodenal region in patients with chronic hepatitis (according to endoscopic and intragastric pH-metric data)]. Ter Arkh (1976) 0.75
[Differential use of immunostimulants with chronic pneumonia patients]. Ter Arkh (1983) 0.75
[Hepatic encephalopathy: its etiology, pathogenesis, clinical diagnostic criteria and treatment principles]. Ter Arkh (1990) 0.75
[Causes of postoperative recurrence and therapy of peptic ulcer]. Klin Med (Mosk) (1990) 0.75
[Role of immune mechanisms in the pathogenesis of peptic ulcer]. Sov Med (1980) 0.75
[Characteristics of respiration in thyrotoxic goiter]. Vestn Khir Im I I Grek (1966) 0.75
[Morpho-functional characteristics of peptic ulcer at the slope of clinical remission]. Vrach Delo (1977) 0.75
[Immunity indices during the use of prodigiozan in treating acute pneumonias]. Sov Med (1980) 0.75
[Effectiveness of cimetidine and ranitidine in peptic ulcer]. Sov Med (1986) 0.75
[Reflux esophagitis in duodenal ulcer and therapeutic problems]. Ter Arkh (1982) 0.75
[Value of scanning in determination of the functional capacity of thyroid gland tissue]. Vestn Khir Im I I Grek (1969) 0.75
[Contemporary trends in pharmacotherapy of intestinal tract diseases]. Klin Med (Mosk) (1999) 0.75
[Comparative evaluation of the efficacy of complex anti-ulcer therapy and monotherapy]. Sov Med (1984) 0.75
[The electrocardiogram in thyreotoxic heart]. Sov Med (1966) 0.75
[Chronic gastritis: current theories on its pathogenesis, clinical course and treatment]. Ter Arkh (1989) 0.75
[The teaching of oncology]. Vopr Onkol (1971) 0.75
[Characteristics of the endoscopic diagnosis of peptic ulcer and chronic gastritis associated with Campylobacter pylori]. Ter Arkh (1989) 0.75
[Chronic pancreatitis, clinical manifestations and diagnostics]. Eksp Klin Gastroenterol (2007) 0.75
[The rational use of De-Nol in the treatment of peptic ulcer and chronic active gastroduodenitis associated with Helicobacter pylori]. Ter Arkh (1992) 0.75
[Methods to optimize the management of Helicobacter pylori infection. The comparative efficacy of the triple and quadruple therapy used as a first line therapy]. Eksp Klin Gastroenterol (2004) 0.75
[Work experience of personnel of the institute for aiding practical public health]. Zdravookhr Ross Fed (1967) 0.75
[Experience with transendoscopic ultrasonic therapy of stomach ulcer]. Klin Med (Mosk) (1990) 0.75
[Long-term treatment of peptic ulcer with histamine H2 receptor blockaders: results of their use and new problems]. Klin Med (Mosk) (1991) 0.75
[Iodobromine baths, diadynamic currents and ultrasonics in the overall treatment of gastric and duodenal peptic ulcer]. Vopr Kurortol Fizioter Lech Fiz Kult (1980) 0.75
[Pharmacotherapy of stomach and duodenal ulcers]. Sov Med (1986) 0.75
[Experience with endoscopy]. Vrach Delo (1978) 0.75
[Indices of immunological reactivity in peptic ulcer]. Vrach Delo (1980) 0.75
[Use of sucralfate in the treatment of peptic ulcer]. Klin Med (Mosk) (1989) 0.75
[The treatment of peptic ulcer patients with calcitrin]. Vrach Delo (1990) 0.75
[Development of acute stomach ulcer in diabetes mellitus]. Vrach Delo (1980) 0.75
[Chronic primary gastroduodenitis]. Ter Arkh (1992) 0.75
[Phases of peptic ulcer]. Klin Med (Mosk) (1989) 0.75
[Determination of the degree of seeding by Helicobacter pylori in the gastric mucosa]. Lab Delo (1991) 0.75
[Clinical assessment of the changes in the ventricular complex of the ECG in thyreotoxic goiter]. Ter Arkh (1966) 0.75
[Gastrotsepin in the therapy and prevention of peptic ulcer exacerbations associated with Helicobacter pylori bacteriosis]. Klin Med (Mosk) (1995) 0.75
[Criteria for evaluation of rehabilitation results in patients with peptic ulcer]. Klin Med (Mosk) (1980) 0.75
[Experience with the use of foreign fiber optics apparatus]. Med Tekh (1982) 0.75
[Staged treatment of peptic ulcer recurrence]. Klin Med (Mosk) (1981) 0.75
[Famotidine--a new histamine H2 receptor blockader]. Klin Med (Mosk) (1991) 0.75
[The role of the polyclinic in raising the efficacy of rehabilitation with peptic ulcer patients]. Ter Arkh (1992) 0.75
[Clinical and morphologic comparisons in toxic goiter]. Arkh Patol (1967) 0.75
[The effectiveness of 7-day combined Helicobacter eradication therapy in patients with peptic ulcer and chronic gastritis]. Klin Med (Mosk) (2001) 0.75
[Litholytic therapy of gallstones]. Voen Med Zh (1987) 0.75
[Diagnosis and treatment of hemochromatosis in women]. Klin Med (Mosk) (1981) 0.75
[Use of andekalin in the complex treatment of patients with peptic ulcer and chronic gastroduodenitis]. Vrach Delo (1986) 0.75
[Evaluation of long-term conservative treatment of ulcer disease]. Klin Med (Mosk) (1975) 0.75
[Treatment of peptic ulcer]. Sov Med (1983) 0.75
[Synthetic analog of prostaglandin E2 (enprostil) in the treatment of peptic ulcer]. Sov Med (1991) 0.75
[Endoscopic characteristics of gastroduodenal zone in patients with ulcer disease]. Sov Med (1976) 0.75
[Local factors in the pathogenesis of peptic ulcer]. Klin Med (Mosk) (1988) 0.75
[Drug therapy and therapeutic tactics in gastroduodenal ulcer]. Ter Arkh (1988) 0.75
[Disorder in mechanisms of bile formation and methods of their correction]. Eksp Klin Gastroenterol (2003) 0.75
[The comparative efficacy of ranitidine and famotidine in treating exacerbations of duodenal peptic ulcer]. Klin Med (Mosk) (1993) 0.75
[Principles of classification of peptic ulcer]. Vrach Delo (1977) 0.75
[Cytoprotectors in stomach diseases therapy. Best practice in the drug selection]. Eksp Klin Gastroenterol (2006) 0.75
[Chronic primary gastroduodenitis and Helicobacter pylori--their relationship]. Sov Med (1991) 0.75
[Current views on the etiology and pathogenesis of peptic ulcer]. Vestn Akad Med Nauk SSSR (1990) 0.75
[Campylobacter pyloridis in chronic gastritis and peptic ulcer]. Sov Med (1988) 0.75
[Current concepts of chronic gastritis (a review of the literature)]. Vrach Delo (1988) 0.75
[Thirty years of practice in treatment of ulcer]. Klin Med (Mosk) (1999) 0.75
[A course and outcome of chronic hepatitis with the presence of serum markers of replication phase of hepatitis B virus]. Sov Med (1991) 0.75
[Helicobacter pylori infection in patients with liver cirrhosis: diagnostics and problems of therapy]. Eksp Klin Gastroenterol (2006) 0.75
[Trypsin and C-peptide concentration in the blood serum of patients with chronic pancreatitis]. Vrach Delo (1989) 0.75
[The drug treatment of gastric and duodenal peptic ulcer]. Ter Arkh (1995) 0.75
[Pathogenesis of bronchial asthma]. Vrach Delo (1976) 0.75
[Practical recommendations regarding the treatment and prevention of peptic ulcer]. Sov Med (1991) 0.75
[Experience in increasing the effectiveness of patient rehabilitation in peptic ulcer]. Klin Med (Mosk) (1984) 0.75
[Treatment of peptic ulcer with ulcosilvanil]. Sov Med (1984) 0.75
[Complex conservative treatment of thyreotoxic goiter]. Sov Med (1969) 0.75
[Gastroduodenal diseases associated with helicobacter pylori]. Klin Med (Mosk) (1998) 0.75
[Relapse and remission in peptic ulcer]. Klin Med (Mosk) (1977) 0.75
[Chronic pancreatitis: current theories on its etiology, pathogenesis, clinical course and drug treatment (review of foreign literature)]. Klin Med (Mosk) (1988) 0.75
[Pathophysiologic bases of the pharmacotherapy of peptic ulcer]. Klin Med (Mosk) (1988) 0.75
[Peptic ulcer associated with reflux esophagitis and its treatment]. Sov Med (1981) 0.75
[Ambulatory care of patients with a history of acute pneumonia]. Vrach Delo (1981) 0.75
[Treatment of peptic ulcer with gastrozepin]. Sov Med (1984) 0.75
[New aspects in the etiology and pathogenesis of chronic gastritis and peptic ulcer]. Ter Arkh (1988) 0.75
[The pathogenetic bases of alimentary obesity]. Ter Arkh (1989) 0.75
[Clinical aspects and diagnosis of chronic viral hepatitis B]. Klin Med (Mosk) (1984) 0.75
[The drug prophylaxis of peptic ulcer exacerbations]. Ter Arkh (1995) 0.75
[The content of regulatory peptides in the blood of patients with chronic gastric and duodenal diseases]. Vrach Delo (1989) 0.75
[Diagnosis and treatment of chronic hepatitis and liver cirrhosis]. Sov Med (1985) 0.75
[A method of determining Campylobacter pylori in the gastric mucosa in peptic ulcer and chronic gastritis]. Lab Delo (1989) 0.75
[The treatment of patients with chronic primary gastroduodenitis]. Vrach Delo (1991) 0.75
[Use of sodium oxyferriscorbone, lidocaine and therapeutic endoscopy in peptic ulcer]. Vrach Delo (1984) 0.75
[Osmotic resistance of the thrombocytes and capillary resistance in hepatocholecystitis and liver cirrhosis]. Lab Delo (1968) 0.75